Let’s share care with the world

By choosing Maersk ECO Delivery Ocean, this pharma company was able to get closer to their decarbonisation goals while still delivering essential care all around the world. 

India is a global pharmaceutical powerhouse, on course to being a $450 billion industry by 2047. The country contributes to over 20% of the world's drug supply chain and manufactures over 60% of the global demand for vaccines. What makes the pharma industry tick in India? How are the latest innovations in technology changing the face of how the sector is run and the medicines transported? What supply chain challenges does it encounter?
Read our article for a comprehensive understanding of the latest developments and challenges in the Indian pharma industry.

In our modern, globalised world, where cross-border trade contributes 50% to GDP, the pharmaceutical & healthcare sectors have faced unprecedented challenges. Professionals in these fields are now navigating a shift towards reliability, transparency, and intelligence in supply chains.

Our e-book delves into this evolving landscape, assessing innovations and envisioning the future of pharmaceutical & healthcare logistics. Explore how Maersk pioneers end-to-end innovation through advancements in processes, technology, and collaborative efforts.

Transporting the most fragile, high-value, regulated cargo in the world is complex. Even more so when you need to roll out billions of doses of a vaccine across continents to every person on the planet. Add to that the pressures of running a greener supply chain and pharma companies could find themselves in a dilemma. Unless they add a healthy dose of shipping to their modal mix. It’s reliable, makes essential products accessible to patients around the globe, and emits considerably less CO2 than most other modes of transportation.